{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:12Z","timestamp":1793832312611,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Regional citrate anticoagulation (RCA) is the recommended anticoagulation strategy for continuous kidney replacement therapy (CKRT). However, the safety of RCA in patients with liver dysfunction and\/or shock remains controversial due to the risk of citrate accumulation. This study assesses the associations of citrate accumulation with liver dysfunction, circulatory shock, and mortality, and investigates lactate and the vasoactive inotropic score (VIS) as early predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included critically ill patients requiring RCA-based CKRT between January 2018 and March 2022. Lactate, VIS and parameters of organ failure were investigated as predictors of citrate accumulation. An albumin-corrected total calcium to ionized calcium ratio\u2009\u2265\u20092.5 was used to define citrate accumulation. Regression models were employed to investigate the association of predictors with outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine hundred eleven patients were included, citrate accumulation was observed in 159 individuals (17%). Factors related to liver dysfunction, but not circulatory shock, were attributed to citrate accumulation. After multivariable adjustment, citrate accumulation was not associated with mortality. Lactate measured before onset of CKRT showed an improved discriminative performance compared to the VIS. The odds of citrate accumulation increased by 2.34 (CI 1.94\u20132.85,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) for each one-unit increase in lactate on the logarithmic scale (log mmol\/L). The probability for citrate accumulation ranged from 3.3 (CI 2.06\u20135.28) % at lactate levels of 0.3 mmol\/L to 59.8 (CI 48.88\u201369.78) % at levels of 25 mmol\/L.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lactate is a reliable predictor for assessing the risk of citrate accumulation in patients undergoing CKRT. Further research is needed to develop and validate predictive algorithms for various anticoagulation strategies to offer reliable support for personalized decision-making in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-025-05691-2","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:40:13Z","timestamp":1762166413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Incidence, severity, and predictors of citrate accumulation during continuous kidney replacement therapy in the critically ill"],"prefix":"10.1186","volume":"29","author":[{"given":"Mattia M.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bartussek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Buhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Kadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Erlebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Hofmaenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rea","family":"Andermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Thorsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto A.","family":"Schuepbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph C.","family":"Ganter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro D.","family":"Wendel-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"1","key":"5691_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ndt\/gfq575","volume":"26","author":"GR Hetzel","year":"2011","unstructured":"Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant. 2011;26(1):232\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfq575.","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"5691_CR2","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, Kullmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629\u201339. https:\/\/doi.org\/10.1001\/jama.2020.18618.","journal-title":"JAMA"},{"issue":"12","key":"5691_CR3","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098\u2013110. https:\/\/doi.org\/10.1007\/s00134-015-4099-0.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5691_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000529076","volume":"52","author":"R Ratanarat","year":"2023","unstructured":"Ratanarat R, Phairatwet P, Khansompop S, Naorungroj T. Customized citrate anticoagulation versus no anticoagulant in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a prospective randomized controlled trial. Blood Purif. 2023;52(5):455\u201363. https:\/\/doi.org\/10.1159\/000529076.","journal-title":"Blood Purif"},{"key":"5691_CR5","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2013;2(1):1\u2013138."},{"issue":"1","key":"5691_CR6","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41598-022-05867-8","volume":"12","author":"P Thanapongsatorn","year":"2022","unstructured":"Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N, et al. Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep. 2022;12(1):1815. https:\/\/doi.org\/10.1038\/s41598-022-05867-8.","journal-title":"Sci Rep"},{"issue":"1","key":"5691_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmele T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21(1):281. https:\/\/doi.org\/10.1186\/s13054-017-1880-1.","journal-title":"Crit Care"},{"issue":"1","key":"5691_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","volume":"3","author":"V Pistolesi","year":"2023","unstructured":"Pistolesi V, Morabito S, Pota V, Valente F, Di Mario F, Fiaccadori E, et al. Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission. J Anesth Analg Crit Care. 2023;3(1):7. https:\/\/doi.org\/10.1186\/s44158-023-00091-w.","journal-title":"J Anesth Analg Crit Care"},{"issue":"9","key":"5691_CR9","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med. 2017;45(9):e941\u20136. https:\/\/doi.org\/10.1097\/CCM.0000000000002501.","journal-title":"Crit Care Med"},{"issue":"6","key":"5691_CR10","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1111\/aas.70060","volume":"69","author":"JU Ulrichsen","year":"2025","unstructured":"Ulrichsen JU, Plovsing RR, Foss NB, Berg RMG, Iepsen UW. Lactate as a predictor of citrate accumulation in patients undergoing continuous renal replacement therapy? A systematic review. Acta Anaesthesiol Scand. 2025;69(6):e70060. https:\/\/doi.org\/10.1111\/aas.70060.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"5691_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related organ failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on Sepsis-Related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707\u201310. https:\/\/doi.org\/10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"issue":"2","key":"5691_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-2008-1040593","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6(2):97\u2013106. https:\/\/doi.org\/10.1055\/s-2008-1040593.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"5691_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O\u2019Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439\u201345. https:\/\/doi.org\/10.1016\/0016-5085(89)90081-4.","journal-title":"Gastroenterology"},{"issue":"12","key":"5691_CR14","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s00134-008-1199-0","volume":"34","author":"F Vallee","year":"2008","unstructured":"Vallee F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med. 2008;34(12):2218\u201325. https:\/\/doi.org\/10.1007\/s00134-008-1199-0.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5691_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/cc9310","volume":"14","author":"E Futier","year":"2010","unstructured":"Futier E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE, et al. Central venous O(2) saturation and venous-to-arterial CO(2) difference as complementary tools for goal-directed therapy during high-risk surgery. Crit Care. 2010;14(5):R193. https:\/\/doi.org\/10.1186\/cc9310.","journal-title":"Crit Care"},{"issue":"4","key":"5691_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","volume":"29","author":"HU Meier-Kriesche","year":"2001","unstructured":"Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29(4):748\u201352. https:\/\/doi.org\/10.1097\/00003246-200104000-00010.","journal-title":"Crit Care Med"},{"issue":"7","key":"5691_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00134-012-2544-x","volume":"38","author":"J Davidson","year":"2012","unstructured":"Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med. 2012;38(7):1184\u201390. https:\/\/doi.org\/10.1007\/s00134-012-2544-x.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5691_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23(1):22. https:\/\/doi.org\/10.1186\/s13054-019-2317-9.","journal-title":"Crit Care"},{"issue":"1","key":"5691_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-020-2801-2","volume":"24","author":"PM Honore","year":"2020","unstructured":"Honore PM, Mugisha A, David C, Attou R, Redant S, Gallerani A, et al. In severe liver disease, citrate can be used safely: the question remains-by which mechanism. Crit Care. 2020;24(1):63. https:\/\/doi.org\/10.1186\/s13054-020-2801-2.","journal-title":"Crit Care"},{"key":"5691_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155032","volume":"87","author":"D Bachmann","year":"2025","unstructured":"Bachmann D, Monard C, Kelevina T, Ahmad Y, Pruijm M, Chiche JD, et al. Generalization of regional citrate anticoagulation for continuous renal replacement therapy is not associated with an increased rate of severe complications. J Crit Care. 2025;87:155032. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155032.","journal-title":"J Crit Care"},{"issue":"2","key":"5691_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ckj\/sfac223","volume":"16","author":"HHM To","year":"2023","unstructured":"To HHM, Kwan AMC, Leung NYY, Chan WM, Ngai CW, Wong ASK, et al. A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation. Clin Kidney J. 2023;16(2):285\u201392. https:\/\/doi.org\/10.1093\/ckj\/sfac223.","journal-title":"Clin Kidney J"},{"key":"5691_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2020.05.005","volume":"59","author":"W Boer","year":"2020","unstructured":"Boer W, van Tornout M, Solmi F, Willaert X, Schetz M, Oudemans-van Straaten H. Determinants of Total\/ionized calcium in patients undergoing citrate CVVH: A retrospective observational study. J Crit Care. 2020;59:16\u201322. https:\/\/doi.org\/10.1016\/j.jcrc.2020.05.005.","journal-title":"J Crit Care"},{"issue":"4","key":"5691_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/1744-9987.12656","volume":"22","author":"M Siebeck","year":"2018","unstructured":"Siebeck M, Dimski T, Brandenburger T, Slowinski T, Kindgen-Milles D. Super high-flux continuous venovenous hemodialysis using regional citrate anticoagulation: long-term stability of middle molecule clearance. Ther Apher Dial. 2018;22(4):355\u201364. https:\/\/doi.org\/10.1111\/1744-9987.12656.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"5691_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-023-00581-9","volume":"11","author":"MM Muller","year":"2023","unstructured":"Muller MM, Caspar L, Sazpinar O, Hofmaenner DA, Erlebach R, Andermatt R, et al. Metabolic disturbances potentially attributable to clogging during continuous renal replacement therapy. Intensive Care Med Exp. 2023;11(1):99. https:\/\/doi.org\/10.1186\/s40635-023-00581-9.","journal-title":"Intensive Care Med Exp"},{"issue":"3","key":"5691_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/cc11363","volume":"16","author":"A Link","year":"2012","unstructured":"Link A, Klingele M, Speer T, Rbah R, Poss J, Lerner-Graber A, et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012;16(3):R97. https:\/\/doi.org\/10.1186\/cc11363.","journal-title":"Crit Care"},{"issue":"4","key":"5691_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA. The science and translation of lactate shuttle theory. Cell Metab. 2018;27(4):757\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.008.","journal-title":"Cell Metab"},{"issue":"2","key":"5691_CR27","doi-asserted-by":"publisher","first-page":"e0192796","DOI":"10.1371\/journal.pone.0192796","volume":"13","author":"C Sumi","year":"2018","unstructured":"Sumi C, Okamoto A, Tanaka H, Nishi K, Kusunoki M, Shoji T, et al. Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner. PLoS ONE. 2018;13(2):e0192796. https:\/\/doi.org\/10.1371\/journal.pone.0192796.","journal-title":"PLoS ONE"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05691-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:19:41Z","timestamp":1781612381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05691-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5691"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05691-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations\u00a0"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with established ethical standards and the Declaration of Helsinki. The Cantonal Ethics Commission of Zurich, Switzerland (Kantonale Ethikkommission Z\u00fcrich, BASEC-ID: 2022\u221201938) reviewed and approved the study protocol. Due to the retrospective nature of the study and in compliance with local regulations, informed consent was waived. Patients were excluded if they had explicitly declined the use of their medical data either verbally or in writing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"468"}}